Evergy vs WEC Energy
EVRG and WEC side by side, both in combination electric and gas, and other utility. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How EVRG and WEC compare
WEC Energy is the larger company, worth 1.9 times as much as Evergy ($37.8B against $19.8B).
On earnings, WEC Energy is cheaper: it trades at 21.1× trailing earnings, against 21.8× for Evergy.
WEC Energy grew revenue faster over the last twelve months (8.1% versus 3.6% for Evergy).
Both pay dividends: Evergy yields 3.2% and WEC Energy 3.2%.
Evergy scores higher on the StockData Score (7 against 4 for WEC Energy), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | EVRG | WEC |
|---|---|---|
| Size and price | ||
| Market cap | $19.8B | $37.8B |
| Share price | $85.93 | $116.07 |
| Change, 1 year | 11.7% | 1.3% |
| Change, 5 years | 32.4% | 27.7% |
| Beta (5Y) | 0.35 | 0.27 |
| Employees | 4,691 | 7,151 |
| StockData Score | ||
| Total score | 7 (better) | 4 |
| Valuation score | 0 | 1 (better) |
| Growth score | 1 | 1 |
| Performance score | 3 (better) | 0 |
| Health score | 0 | 0 |
| Dividend score | 3 (better) | 2 |
| Valuation | ||
| P/E | 21.8× | 21.1× (better) |
| P/S | 3.3× (better) | 3.7× |
| P/B | 1.9× | – |
| EV/EBITDA | 12.1× (better) | 15.3× |
| PEG | 5.70 (better) | 8.02 |
| FCF yield | −7.1% | – |
| Fair value | $75.82 | $112.71 |
| Margin of safety | −13.3% | −3.0% (better) |
| Growth | ||
| Revenue growth (TTM) | 3.6% | 8.1% (better) |
| Revenue growth, 5Y average | 3.9% | 6.2% (better) |
| Net income growth (TTM) | 10.2% | – |
| EPS growth (TTM) | 8.2% (better) | 4.2% |
| EPS growth, 5Y average | 6.1% (better) | 4.9% |
| Profitability | ||
| Gross margin | – | 65.9% |
| Operating margin | 26.2% (better) | 23.5% |
| Net margin | 15.2% | – |
| FCF margin | −23.1% | – |
| Return on equity | 9.2% | – |
| Return on invested capital | 6.4% | – |
| Financial health | ||
| Debt / equity | 1.35 | – |
| Net debt / EBITDA | 4.94 (better) | 5.73 |
| Interest coverage | 2.5× | 2.6× (better) |
| Current ratio | 0.36 | 0.53 (better) |
| Altman Z-score | 0.79 | 1.10 (better) |
| Piotroski F-score | 3 | – |
| Dividends and buybacks | ||
| Dividend yield | 3.2% (better) | 3.2% |
| Payout ratio | 67.4% | – |
| Years of dividend growth | 9 | 12 (better) |
| Dividend growth, 5Y average | 5.6% | 7.1% (better) |
| Buyback yield | −0.01% (better) | −1.1% |
| Shareholder yield | 3.2% (better) | 2.2% |
| Ownership | ||
| Held by institutions | 94.5% | 86.2% |
| Held by insiders | 1.3% | 0.16% |
| Insider net buying, 12 months | −$1.7M (better) | −$5.9M |
| Short interest, % of float | 8.1% | 4.4% |
Go deeper
- EVRG stock overview
- EVRG income statement
- EVRG valuation and score
- WEC stock overview
- WEC income statement
- WEC valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.